#drugdevelopment — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #drugdevelopment, aggregated by home.social.
-
https://www.europesays.com/uk/988371/ Industry and regulators signal a smarter, collaborative era for supplement oversight #america #approval #building #Certification™ #ClinicalTrials #Drug #DrugDevelopment #exterior #FDA #FdaApproval #FdaApproved #Federal #FoodAdditives #Health #HealthAndHumanServices #HealthCare #HHS #landmark #Maryland #Medication #NavalOrdnanceLaboratory #Nutrition #outdoor #park #Policy #Regulation #RestrictedArea #Trees #UK #UnitedKingdom #Urban #Vaccine #VaccineDevelopment
-
https://www.europesays.com/ie/505339/ Industry and regulators signal a smarter, collaborative era for supplement oversight #america #approval #building #certification #ClinicalTrials #Drug #DrugDevelopment #Éire #exterior #fda #FDAApproval #FdaApproved #Federal #FoodAdditives #Health #HealthAndHumanServices #HealthCare #hhs #IE #Ireland #landmark #maryland #Medication #NavalOrdnanceLaboratory #Nutrition #outdoor #Park #Policy #Regulation #RestrictedArea #Trees #Urban #Vaccine #VaccineDevelopment
-
https://www.europesays.com/britain/50089/ Kailera, AstraZeneca, Chan Zuckerberg: Readout Newsletter #AstraZeneca #Biotechnology #DrugDevelopment #DrugPrices #research
-
DATE: May 25, 2026 at 09:39AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews
-
DATE: May 25, 2026 at 09:39AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews
-
DATE: May 25, 2026 at 09:39AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews
-
Drug Regulation and Innovation: How Sanofi Collaborates with the FDA
Once an expedited pathway is granted, the therapeutics dossier – a thorough collection of documents submitted to the…
#France #FR #Europe #EU #Sanofi #Approval #drugdevelopment #DrugSafety #Expedited #FDA #regulatory #review
https://www.europesays.com/france/19189/ -
https://www.alojapan.com/1487848/hokkaido-university-leverages-bostongenes-ai-powered-platform-to-advance-precision-oncology-3/ Hokkaido University Leverages BostonGene’s AI-powered Platform to Advance Precision Oncology #AIFoundation #CancerPatients #DrugDevelopment #Hokkaido #HokkaidoNews #HokkaidoUniversity #ImmuneSystem #Japan #MedicalOncology #news #北海道 Partnership leverages integrated molecular and immune data to drive personalized cancer therapies TOKYO & WALTHAM, Mass., May 12, 2026–(BUSINESS WIRE)–BostonGene, developer of the leading AI foundation model for t
-
https://www.alojapan.com/1487848/hokkaido-university-leverages-bostongenes-ai-powered-platform-to-advance-precision-oncology-3/ Hokkaido University Leverages BostonGene’s AI-powered Platform to Advance Precision Oncology #AIFoundation #CancerPatients #DrugDevelopment #Hokkaido #HokkaidoNews #HokkaidoUniversity #ImmuneSystem #Japan #MedicalOncology #news #北海道 Partnership leverages integrated molecular and immune data to drive personalized cancer therapies TOKYO & WALTHAM, Mass., May 12, 2026–(BUSINESS WIRE)–BostonGene, developer of the leading AI foundation model for t
-
Reposting this article as the topic continues to remain highly relevant for sponsors planning clinical trials in India.
Selecting the right CRO can significantly influence study execution, compliance, patient recruitment, and overall development timelines.
In this article, we share practical considerations for choosing a CRO partner aligned with both scientific and operational goals.
#ClinicalResearch #CROIndia #ClinicalTrials #DrugDevelopment
https://genelifecr.blogspot.com/2026/04/how-to-choose-cro-in-india-key-factors.html
-
https://www.europesays.com/news/28725/ Regenxbio says Duchenne gene therapy succeeded in clinical trial #biotechnology #DrugDevelopment #Headlines #News #Pharmaceuticals #RareDiseases #STAT+ #TopStories
-
We published an article on Monday about India's biosimilar regulatory framework.
We are reposting the article again, in case you missed that:
#Biosimilars #ClinicalResearch #CRO #Pharma #Biologics #DrugDevelopment #CDSCO #RegulatoryAffairs #Pharmacovigilance #RWE
https://genelifecr.blogspot.com/2026/05/biosimilar-regulation-in-india-evolving.html
-
https://www.europesays.com/ch/63807/ Novartis Bets on India R&D Hub Post-Divestment #Ahmedabad #CardiovascularDisease #ClinicalTrials #DrugDevelopment #GlobalHub #Immunology #India #Novartis #Oncology #PharmaceuticalInnovation #R&D
-
https://www.europesays.com/dk/80004/ Novo Nordisk and OpenAI forge alliance to drive speedy drug development #DrugDevelopment #DrugDiscovery #EliLilly #NovoNordisk #ObesityAndDiabetes #openai #tech
-
https://www.europesays.com/dk/79980/ Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior #ArtificialIntelligence #Biotechnology #CellTherapy #CellularIntelligence #ClinicalTrials #DopaminergicNeurons #DrugDevelopment #MichaBreakstone #neurology #NovoNordisk #Parkinson'sDisease #SomiteAI #StemCellResearch #STEMPD #VentureCapital
-
Our latest article explores the changing regulatory framework for biosimilars in India.
As the industry moves toward a more science-driven and risk-based approach, understanding the evolving biosimilar ecosystem becomes increasingly important for sponsors, researchers, and healthcare stakeholders.
#Biosimilars #ClinicalResearch #CRO #Pharma #Biologics #DrugDevelopment #CDSCO #RegulatoryAffairs #Pharmacovigilance #RWE
https://genelifecr.blogspot.com/2026/05/biosimilar-regulation-in-india-evolving.html
-
Congratulations to Craig @crews and all others involved at Yale University, Arvinas and Pfizer. #InducedProximity should be at the top of many Nobel Prize lists now. (2/2)
#TPD #TargetedProteinDegradation #NewModalities #Clinics #DrugDiscovery #DrugDevelopment #Success
-
Congratulations to Craig @crews and all others involved at Yale University, Arvinas and Pfizer. #InducedProximity should be at the top of many Nobel Prize lists now. (2/2)
#TPD #TargetedProteinDegradation #NewModalities #Clinics #DrugDiscovery #DrugDevelopment #Success
-
Congratulations to Craig @crews and all others involved at Yale University, Arvinas and Pfizer. #InducedProximity should be at the top of many Nobel Prize lists now. (2/2)
#TPD #TargetedProteinDegradation #NewModalities #Clinics #DrugDiscovery #DrugDevelopment #Success
-
Congratulations to Craig @crews and all others involved at Yale University, Arvinas and Pfizer. #InducedProximity should be at the top of many Nobel Prize lists now. (2/2)
#TPD #TargetedProteinDegradation #NewModalities #Clinics #DrugDiscovery #DrugDevelopment #Success
-
https://www.europesays.com/uk/947629/ 3 Stocks Poised to Disrupt the Healthcare Market by 2030 #BlockbusterDrugs #DrugDevelopment #GenomicData #Health #Healthcare #HealthcareProviders #HealthcareStocks #HealthcareSystem #Pharmaceuticals #PredictableRevenue #Recursion #Therapeutics #UK #UnitedKingdom
-
https://www.europesays.com/ie/475785/ 3 Stocks Poised to Disrupt the Healthcare Market by 2030 #BlockbusterDrugs #DrugDevelopment #Éire #GenomicData #Health #HealthCare #Healthcare #HealthcareProviders #HealthcareStocks #HealthcareSystem #IE #Ireland #pharmaceuticals #PredictableRevenue #Recursion #Therapeutics
-
3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
#NewsBeep #News #Healthcare #AU #Australia #blockbusterdrugs #drugdevelopment #genomicdata #Health #healthcareproviders #healthcarestocks #HealthcareSystem #Pharmaceuticals #predictablerevenue #Recursion #Therapeutics
https://www.newsbeep.com/au/658950/ -
3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
#NewsBeep #News #Healthcare #AU #Australia #blockbusterdrugs #drugdevelopment #genomicdata #Health #healthcareproviders #healthcarestocks #HealthcareSystem #Pharmaceuticals #predictablerevenue #Recursion #Therapeutics
https://www.newsbeep.com/au/658950/ -
3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
#NewsBeep #News #Healthcare #blockbusterdrugs #drugdevelopment #genomicdata #Health #healthcare #healthcareproviders #healthcarestocks #HealthcareSystem #Pharmaceuticals #predictablerevenue #Recursion #Therapeutics #UK #UnitedKingdom
https://www.newsbeep.com/uk/573889/ -
Blackstone Commits $250 Million to Anagram Therapeutics, Targeting Cystic Fibrosis Complication
Blackstone Life Sciences invests $250 million in Anagram Therapeutics to develop a new drug for cystic fibrosis patients with EPI. This could mean fewer pills daily.
#CysticFibrosis, #Blackstone, #AnagramTherapeutics, #EPI, #DrugDevelopment
https://newsletter.tf/blackstone-gives-250m-to-help-cf-patients/
-
Blackstone Life Sciences is giving $250 million to Anagram Therapeutics. This is a large amount of money to help develop a new medicine for people with cystic fibrosis.
#CysticFibrosis, #Blackstone, #AnagramTherapeutics, #EPI, #DrugDevelopment
https://newsletter.tf/blackstone-gives-250m-to-help-cf-patients/ -
Most clinical trials don't fail because the science was wrong.
They fail because:
→ Sites weren't activated on time
→ Enrollment targets were optimistic, not evidence-based
→ Data issues were caught late
→ No one owned the full picture
That's a project management problem — not a scientific one.
We wrote about how structured clinical project management prevents exactly this.#clinicalresearch #clinicaltrials #projectmanagement #CRO #pharma #drugdevelopment
https://genelifecr.blogspot.com/2026/05/clinical-project-management-in-clinical.html -
FDA turmoil casts shadow over gene therapy conference in Europe
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
#Europe #EU #drugdevelopment #FDA #policy #raredisease #STAT+
https://www.europesays.com/europe/32957/ -
Wall Street Journal: The quest to use AI to help find new drugs. “Lilly first announced a partnership with chip-maker Nvidia in October to build what it called the industry’s most powerful supercomputer, and expanded that in January with a $1 billion, five-year collaboration mixing their scientists and engineers in a new Bay Area lab aimed at discovering new medicines with AI tools. They […]
https://rbfirehose.com/2026/05/05/wall-street-journal-the-quest-to-use-ai-to-help-find-new-drugs/ -
Wall Street Journal: The quest to use AI to help find new drugs. “Lilly first announced a partnership with chip-maker Nvidia in October to build what it called the industry’s most powerful supercomputer, and expanded that in January with a $1 billion, five-year collaboration mixing their scientists and engineers in a new Bay Area lab aimed at discovering new medicines with AI tools. They […]
https://rbfirehose.com/2026/05/05/wall-street-journal-the-quest-to-use-ai-to-help-find-new-drugs/ -
Wall Street Journal: The quest to use AI to help find new drugs. “Lilly first announced a partnership with chip-maker Nvidia in October to build what it called the industry’s most powerful supercomputer, and expanded that in January with a $1 billion, five-year collaboration mixing their scientists and engineers in a new Bay Area lab aimed at discovering new medicines with AI tools. They […]
https://rbfirehose.com/2026/05/05/wall-street-journal-the-quest-to-use-ai-to-help-find-new-drugs/ -
Wall Street Journal: The quest to use AI to help find new drugs. “Lilly first announced a partnership with chip-maker Nvidia in October to build what it called the industry’s most powerful supercomputer, and expanded that in January with a $1 billion, five-year collaboration mixing their scientists and engineers in a new Bay Area lab aimed at discovering new medicines with AI tools. They […]
https://rbfirehose.com/2026/05/05/wall-street-journal-the-quest-to-use-ai-to-help-find-new-drugs/ -
Wall Street Journal: The quest to use AI to help find new drugs. “Lilly first announced a partnership with chip-maker Nvidia in October to build what it called the industry’s most powerful supercomputer, and expanded that in January with a $1 billion, five-year collaboration mixing their scientists and engineers in a new Bay Area lab aimed at discovering new medicines with AI tools. They […]
https://rbfirehose.com/2026/05/05/wall-street-journal-the-quest-to-use-ai-to-help-find-new-drugs/ -
In our latest article, we explore how Clinical Project Managementserves as the backbone of successful clinical trials — ensuring efficiency, quality, and compliance from study design to completion.
If you're involved in clinical development, this provides a comprehensive view of how integrated project management drives better outcomes.
#ClinicalResearch #CRO #ClinicalTrials #ProjectManagement #Pharma #DrugDevelopment #genelifehttps://genelifecr.blogspot.com/2026/05/clinical-project-management-in-clinical.html
-
A non-antibiotic erythromycin derivative improves muscle endurance by regulating endogenous anti-fatigue protein orosomucoid in mice [2024]
-
A non-antibiotic erythromycin derivative improves muscle endurance by regulating endogenous anti-fatigue protein orosomucoid in mice [2024]
-
A non-antibiotic erythromycin derivative improves muscle endurance by regulating endogenous anti-fatigue protein orosomucoid in mice [2024]
-
A non-antibiotic erythromycin derivative improves muscle endurance by regulating endogenous anti-fatigue protein orosomucoid in mice [2024]
-
Erythromycin has therapeutic efficacy on muscle fatigue acting specifically on orosomucoid to increase muscle bioenergetics and physiological parameters of endurance [2020]
abstract:
https://pubmed.ncbi.nlm.nih.gov/32777256/preprint can be downloaded here:
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3463265#orosomucoid #fatigue #erythromycin #DrugRepurposing #DrugDevelopment
-
Erythromycin has therapeutic efficacy on muscle fatigue acting specifically on orosomucoid to increase muscle bioenergetics and physiological parameters of endurance [2020]
abstract:
https://pubmed.ncbi.nlm.nih.gov/32777256/preprint can be downloaded here:
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3463265#orosomucoid #fatigue #erythromycin #DrugRepurposing #DrugDevelopment
-
Erythromycin has therapeutic efficacy on muscle fatigue acting specifically on orosomucoid to increase muscle bioenergetics and physiological parameters of endurance [2020]
abstract:
https://pubmed.ncbi.nlm.nih.gov/32777256/preprint can be downloaded here:
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3463265#orosomucoid #fatigue #erythromycin #DrugRepurposing #DrugDevelopment
-
Erythromycin has therapeutic efficacy on muscle fatigue acting specifically on orosomucoid to increase muscle bioenergetics and physiological parameters of endurance [2020]
abstract:
https://pubmed.ncbi.nlm.nih.gov/32777256/preprint can be downloaded here:
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3463265#orosomucoid #fatigue #erythromycin #DrugRepurposing #DrugDevelopment
-
https://www.europesays.com/britain/25193/ AstraZeneca to inject £300 million into UK in surprise U-turn #AstraZeneca #Cambridge #DrugDevelopment #INVESTMENT #KeirStarmer #Macclesfield #PascalSoriot #SirKeir #UK #UnitedKingdom
-
https://www.europesays.com/news/21622/ Intellia Therapeutics moves HAE treatment closer to approval #biotechnology #CRISPR #DrugDevelopment #FDA #GeneEditing #Headlines #News #RareDiseases #STAT+ #TopStories
-
Erasca touts strong early results in pancreatic and lung cancer therapy trial
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Business #biotechnology #cancer #drugdevelopment #Pharmaceuticals #STAT+
https://www.newsbeep.com/us/610847/ -
Clinical trials alone don’t tell the full story.
In today’s evolving healthcare landscape, companies need more than controlled data — they need real-world insights and market understanding.At Genelife Clinical Research, we integrate all three to help sponsors make smarter clinical and commercial decisions. #ClinicalResearch #CRO #RealWorldEvidence #RWE #Pharma #ClinicalTrials #MarketResearch #DrugDevelopment #HealthcareInsights #LifeSciences #genelife
https://genelifecr.blogspot.com/2026/04/real-world-evidence-vs-market-research.html
-
Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride
Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Business #biotechnology #drugdevelopment #EliLilly #Pharmaceuticals #STAT+
https://www.newsbeep.com/us/596409/
